作者：
Yilin,Chen [1]
;
Na,Xu [2]
;
Yunfan,Yang [3]
;
Zhenfang,Liu [4]
;
Mengxing,Xue [5]
;
Li,Meng [6]
;
Qun,He [7]
;
Chunyan,Chen [8]
;
Qingshu,Zeng [9]
;
Huanling,Zhu [10]
;
Xin,Du [3]
;
Jing,Zou [11]
;
Wenjun,He [1]
;
Jingming,Guo [1]
;
Suning,Chen [12]
;
Guolin,Yuan [5]
;
Hui,Wu [6]
;
Mei,Hong [13]
;
Fanjun,Cheng [14]
;
Bingcheng,Liu [1]
;
Yanli,Zhang [1]
;
Weiming,Li [15]
作者单位：
Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
[1]
Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
[2]
Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
[3]
Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
[4]
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
[5]
Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
[6]
Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
[7]
Department of Hematology, Xiangya Hospital of Central South University, Changsha, China.
[8]
Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
[9]
Department of Hematology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
[10]
Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.
[11]
Department of Hematology, First Clinical Medical College of China Three Gorges University, Yichang Central People's Hospital, Yichang, China.
[12]
Department of Hematology, Xiangyang Central Hospital, The Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
[13]
Department of Hematology, Hanchuan People's Hospital, Hanchuan, China.
[14]
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
[15]
Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
[16]
主题词
人类(Humans);蛋白激酶抑制剂(Protein Kinase Inhibitors);生活质量(Quality of Life);横断面研究(Cross-Sectional Studies);精神卫生(Mental Health);白血病, 髓样, 慢性期(Leukemia, Myeloid, Chronic-Phase);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive)
DOI
10.1002/cam4.6296
PMID
37409506
发布时间
2023-09-16
换一批
换一批
